Market News AIOpen the app

iBio, Inc. was told by Nasdaq that its stock price is too low and could be removed from the market.

TroubleRead the original at SEC EDGAR
Bad for IBIO

iBio missed Nasdaq's $1 closing-bid rule for 30 business days, putting its listing at risk. Trading continues, and it has 180 calendar days to comply, with a possible extra 180 days if it qualifies.

IBIO · iBio, Inc.

AI read · Bad for IBIO

The AI's read

The notice puts iBio's Nasdaq listing at risk if it cannot meet the share-price rule. Trading continues for now, and the company has 180 calendar days to comply. An extra 180 days may be available if iBio meets other listing rules, but delisting remains possible.

Get alerts for IBIO

Follow iBio, Inc. (IBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IBIO
Free on the App Store and Google Play, or on the web.